Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- D&D Pharmatech to Unveil Muscle-Sparing Obesity Drug Data at U.S. Meeting
- I’m A Lifestyle Writer – 5 Health Habits Research Actually Made Me Change
- Are Media Names Nicole Waudby Homes and Lifestyle GM
- Man & his son accused of burglarizing Mesa Arts Center; ED drug linked to eye disease
- ‘90 Day Fiancé’ Alum Unrecognizable After 110
- Luka Doncic-Led Lakers Offseason Workout Video in Slovenia Goes Viral
- Bragg® Reintroduces Its Century-Old Wellness Philosophy
- UPS is investing $2 billion in international, healthcare and supply chain businesses
Browsing: Wellness Tips
ByDaniella Gray Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception,…
–Allowed patent addsto already issued enobosarm specific molecule polymorph composition of matter patents, as well as number of other pending methods of use and formulation patent applications —
As new weight loss medication providers flood the market, Numan has called out the rise of cardboard cut-out care and online hucksters that undermine patient trust in digital healthcare
— Management to host conference call to discuss second quarter 2026 financial results and business update today at 8:00 a.m. ET —
The secret to living longer may not lie in expensive supplements, futuristic therapies or celebrity biohacks. According to Dr Navin Gnanasekaran, radiologist at Apollo Hospitals, Chennai and author of The 100-Year Blueprint, longevity begins with mastering simple daily habits that cost little but demand consistency
Ascletis Pharma has initiated a global Phase III clinical programme for its once-daily oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, ASC30, for chronic weight management, following clearance from the US Food and Drug Administration (FDA)
[Sportschosun, Jang Jong-ho] A recent animal study has found that tirzepatide, which is increasingly being used as an obesity treatment, improves weight, fatty liver and blood sugar levels, but does not sufficiently reduce inflammation and fibrosis in adipose tissue
1 medications continue to grow in popularity for weight loss, but doctors say the number on the scale doesn’t tell the whole story
Ariana Grande, seen here in Los Angeles in November 2025, is planning to take a step away from the spotlight after the conclusion of her tour next month, according to a representative, who said the singer has been subjected to “endless, ongoing public scrutiny.” See all topics

